Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesRadiology/Diagnostic ImagingBlue Cross Blue Shield NM advanced imaging Prior A…
    Ask Trek AI about this page
    ModifiedBlue Cross Blue Shield - New MexicoPolicy N/A

    Advanced Imaging/Radiology prior authorization code list (site-of-care updates)

    Customize your policy alerts

    Sign up for all Blue Cross Blue Shield - New Mexico policy alerts

    Know when Blue Cross Blue Shield - New Mexico releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    List of CPT/HCPCS procedure codes related to advanced imaging/radiology for which prior authorization may be required for BCBSNM networks; indicates management by Carelon and an effective change adding site-of-care to medical necessity criteria as of 01/01/2025. Affects providers submitting claims for listed codes under BCBSNM networks noted.

    Policy Summary
    PayerBlue Cross Blue Shield - New Mexico
    PolicyAdvanced Imaging/Radiology prior authorization code list (site-of-care updates)
    Policy CodePolicy N/A
    Change TypeMedical necessity criteria revisedcode additions/retirements
    Effective DateJan 1, 2025
    Next Review DateN/A
    Key ActionSubmit prior authorization requests to the listed manager (Carelon or BCBSNM) and include site-of-care information where required.
    SourceLink
    POLICY UPDATE CHANGES

    Addition of site of care to the medical necessity criteria for numerous advanced imaging CPT codes.

    Addition of site of care to the medical necessity criteria for multiple advanced imaging CPT codes effective 01/01/2025.

    Multiple CPT panel codes (e.g., 81433, 81436, 81438) are marked as 'Retire Effective 04/01/2025.'

    Multiple Category III codes (e.g., 0476U–0508U and others) are listed with 'Add effective' dates of 07/01/2025 or various 04/01/2025 retirements.

    Some Category III codes are marked 'Retire Effective' with specified dates (e.g., 0396U retire 07/01/2025; 0428U and 0448U retire 04/01/2025).

    01/01/2025date change applies
    40+CPT codes with site-of-care update
    Careloncodes overseen by utilization manager
    20+codes noted with updates adding site of care
    Retire 04/01/2025codes with retire date

    Coverage Criteria and Medical Necessity

    Site-of-care addition to medical necessity criteria

    Codes listed are subject to management and have updated medical necessity criteria.

    site_of_care_added: Medical necessity criteria for the listed advanced imaging CPT codes were updated to include site-of-care considerations effective 01/01/2025.

    Managed by Carelon for prior authorization determinations.

    Panel gene-content criteria

    Panels are defined as covered when they include the required minimum gene set as specified for the condition/panel.

    Panel composition requirement: Genomic sequence analysis panels must include the minimum set of named genes for the indicated condition as specified by the CPT panel code (examples: 81410 requires at least 9 genes including FBN1, TGFBR1, TGFBR2, COL3A1, MYH11, ACTA2, SLC2A10, SMAD3, MYLK; 81413 requires at least 10 cardiac ion channel genes; 81430 requires at least 60 genes for hearing loss panels; 81432 requires at least 10 genes including BRCA1 and BRCA2).minimum gene list per CPT code

    Exact gene lists and minimum counts are provided in the CPT code descriptions in the document.

    The provided excerpt does not include explicit clinical exclusion lists. For specific medical necessity rules, coverage determinations, or exclusions that apply to individual procedure codes, providers must refer to the BCBSNM Medical Policy Website or follow Carelon Medical Benefits Management processes as indicated in the file. Contact information for Carelon is provided for services they handle.

    The document identifies specific coding conflicts for home infusion services that may cause claim denials if billed together. Do not use S9214 with any home infusion per diem code; do not use S9325 with S9326–S9328; do not use S9810 with any per diem code; and do not use S9494 with hourly dosing schedule codes S9497–S9504. These restrictions are listed alongside the S‑codes and the entries note that drugs and nursing visits are billed separately from the S‑per‑diem codes.

    Several molecular genetic panel CPT codes are scheduled for retirement. Notably, duplication/deletion or panel codes such as 81433, 81436, and 81438 are marked 'Retire Effective 04/01/2025' in the code listings; providers should avoid submitting these codes after the stated retirement date and follow updated code guidance from BCBSNM/Carelon.

    The chunks in this section are primarily a managed-code catalog and do not state explicit coverage determinations, medical necessity criteria, or exclusions. They list molecular genetic and related codes with management assignments; specific coverage rules must be confirmed through the payer's medical policy or Carelon's utilization management processes.

    Some Category III and other temporary molecular codes include retire/transition notes. Examples in the catalog show 0380U is marked 'Retire Effective 04/01/2025' and 0396U is marked 'Retire Effective 07/01/2025'. These retirements indicate the codes will be removed or superseded on the effective dates and may affect authorization/claim processing after those dates.

    Additional specific codes in the Category III listings carry retirement dates in-line with their entries. For example, 0428U and 0448U are listed 'Retire Effective 04/01/2025'. Providers should track these retire dates when preparing prior authorization requests or claims for services associated with these temporary codes.

    This segment is a code/service catalog with management assignments and does not provide explicit coverage criteria, medical necessity statements, or exclusions. It lists U‑codes and related entries that are 'Managed By = Carelon' and includes administrative notes such as planned add/retire effective dates for selected codes.

    The listed procedure CPT codes in this section are presented as administrative code listings with a 'Managed By = Carelon' assignment. The excerpt does not provide detailed medical necessity rule text for these surgical/procedure codes; providers should follow Carelon's utilization management instructions for prior authorization and documentation requirements.

    The provided text does not specify items that are explicitly 'not medically necessary.' No not‑medically‑necessary determinations are stated in these chunks; absence of such statements in the excerpt means providers must consult BCBSNM Medical Policy or Carelon guidance for definitive coverage decisions.

    CPT/HCPCS Code Listings

    Molecular Genetic CPT and HCPCS Codes (listed)mixed
    81230Code from source - listed
    81231Code from source - listed
    81232Code from source - listed
    81233Code from source - listed
    81234Code from source - listed
    81235Code from source - listed
    81236Code from source - listed
    81237Code from source - listed
    81238Code from source - listed
    81239Code from source - listed
    1–10 of 186
    1/19

    Provider Actions, Prior Authorization & Documentation

    Prior Authorization

    How to access prior authorization

    This list includes CPT and/or HCPCS codes for which prior authorization or utilization management may be required as of 2025-01-01. Many entries are routed to either Carelon Medical Benefits Management (Carelon) or Blue Cross and Blue Shield of New Mexico (BCBSNM); providers must follow the management/authorization routing indicated for each code.

    • For services managed by Carelon: call 1-866-455-8415 or access https://www.careloninsights.com/medical-benefitsmanagement/specialty-care.
    • This file is a searchable PDF — use Ctrl+F to find codes or descriptions.
    Prior Authorization

    Prior authorization managed by Carelon; site-of-care added to criteria

    Many advanced imaging and radiology CPT/HCPCS codes listed are managed by Carelon. Effective 01/01/2025, medical necessity criteria for multiple advanced imaging codes were updated to include site-of-care requirements. Claims for these codes may be subject to prior authorization/management by Carelon and may be denied or returned if site-of-care documentation is missing or if prior authorization through Carelon was not obtained.

    • Examples (managed by Carelon with site-of-care added effective 01/01/2025): 70336, 70450, 70460, 70470, 70480, 70481, 73706, 73718–73723, 73725, 74150–74178, 74181.
    • Additional advanced imaging/radiology and nuclear medicine PET/SPECT codes (e.g., 78800–78804, 78811–78816, 78830–78832, 0042T, 0633T–0638T, 0648T–0649T, A9602, A9800, C89xx series, G02xx, S8037) are Managed By = Carelon and subject to Carelon utilization management.
    Prior Authorization

    Prior authorization/management assignment — Molecular genetic testing (Managed by Carelon)

    Numerous molecular and genetic laboratory test codes are designated Managed By = Carelon. These codes are subject to Carelon utilization management; providers should submit prior authorization or utilization management requests to Carelon per the contact information above. Some Category III and proprietary U-codes include retirement or effective-date notes — verify code status before submission.

    • Examples: many 00xxU/01xxU/02xxU/03xxU/04xxU and 814xx–813xx series codes are Managed By = Carelon.
    • Code retirement risk example: 0078U is marked for retirement effective 07/01/2025 — use beyond that date may be denied.
    Note

    Provider Actions, Prior Authorization & Documentation

    Some service categories and specific codes are designated Managed By = BCBSNM; prior authorization or utilization management for those codes is handled directly by BCBSNM. Providers should follow BCBSNM authorization processes for these services to avoid claim denials.

    • Examples of BCBSNM-managed codes: 36516, S2120, ENT (30120, 30400–30450 series), cochlear implant codes (L8614–L8629, L8690–L8693), selected gastroenterology (43647–43648, 43881), and home infusion therapy S‑codes (S5501, S5502, S9208–S9213, S9214, S9325, S9357, S9359, S9372–S9376, S9494, S9497, S9500–S9502).
    • title":"BCBSNM-managed service routing","type":"callout","variant":"prior_auth"},{

    Prior Authorization Summary

    Note
    Note
    Note
    Note
    Note
    Note
    Note
    Note
    Note
    Note
    Note
    Note
    Note
    Note
    Note

    Contrast Material and Study Sequencing Rules

    Note
    Note
    Note

    Background and Scope

    This background segment summarizes the document's purpose: it maps a broad set of advanced imaging and molecular testing procedure codes to their utilization manager and provides brief code descriptions. The listings include advanced imaging modalities (CT, MRI, MRA, CTA, PET, SPECT, nuclear medicine), radiopharmaceuticals, quantitative MRI procedures, ENT and cochlear device codes, home infusion per‑diem codes with operational notes, and extensive molecular/genetic testing codes. Many entries include a 'Managed By' field (most often Carelon) and updates such as the addition of site‑of‑care to medical necessity criteria effective 01/01/2025 for numerous advanced imaging CPT codes.

    Definitions and Abbreviations

    site-of-care update
    Site-of-care updateSite of care was added to the medical necessity criteria effective 01/01/2025
    ImplicationProviders should supply site-of-care information when submitting authorization requests to Carelon for affected codes
    Cerebral Perfusion Analysis Using Computed Tomography With Contrast
    0042TCerebral perfusion analysis using CT with contrast (includes post-processing parametric maps for CBF, CBV, MTT)
    Managed ByCarelon (per code entry)
    Quantitative Magnetic Resonance For Analysis Of Tissue Composition
    0648TQuantitative MR for analysis of tissue composition — without diagnostic MRI
    0649TQuantitative MR for analysis of tissue composition — add-on with diagnostic MRI
    Managed By — Carelon
    Managed By = CarelonIndicates the listed CPT/HCPCS code is subject to utilization management by Carelon (third‑party UM vendor)
    Action for providersRoute prior authorization/UM requests to Carelon for codes marked 'Managed By = Carelon'
    81400-81402 — Molecular Pathology Procedure Level 1-3
    81400–81402Molecular Pathology Procedure Levels 1–3 (81400 = Level 1; 81401 = Level 2; 81402 = Level 3)
    UseLevels classify complexity/type of molecular pathology procedures (see code descriptions for examples)
    81402 — Molecular Pathology Procedure Level 3
    81402 (Level 3)Includes non-sequencing target variant analysis covering >10 SNPs, 2–10 methylated variants, immunoglobulin/T-cell receptor gene rearrangements, duplication/deletion of 1 exon, LOH/UPD examples
    ExamplesChromosome deletion analyses, translocation analysis, allelic imbalance assessments listed in code description
    81403 — Molecular Pathology Procedure Level 4
    81403 (Level 4)Analysis of a single exon by DNA sequence analysis, targeted exon analyses, mutation scanning, or >10 amplicons using multiplex PCR in multiple reactions
    ExamplesFull gene sequence analyses and targeted exon sequencing described in code text
    Formalin-Fixed Paraffin-Embedded tissue
    FFPEFormalin‑Fixed Paraffin‑Embedded tissue (abbreviated FFPE)
    ContextMany genomic tests are described as using FFPE tissue in code descriptions
    HCPCS Category III U-code
    HCPCS Category III U-code0XXXXU codes are temporary CPT Category III codes used for emerging molecular genetic laboratory procedures
    ExamplesNumerous U-codes listed (e.g., 0242U, 0244U, 0239U, 0250U) with detailed test descriptions
    Managed By — identification
    Managed By (definition)'Managed By = Carelon' identifies the utilization management entity responsible for the code (Carelon)
    Provider actionSubmit prior authorization/UM requests to the named manager per code entry
    Category III code definition
    Category III (0XXXXU) definitionCPT Category III temporary codes for emerging or technology-specific molecular genetic testing services
    ImplicationThese codes may have add/retire effective dates noted and are managed by Carelon per the document
    Molecular Genetic Lab Testing (examples in list)
    Molecular genetic lab testing examplesIncludes targeted gene panels, methylation analyses, ctDNA assays, whole genome/exome sequencing panels and proprietary expression algorithms (multiple U‑codes and 8xxxx codes listed)
    Provider noteThese tests are assigned 'Managed By = Carelon' in the listing and require routing to the named manager for utilization management
    Management entity
    Management entity (shorthand)Managed By = Carelon (management/authorization vendor responsible for listed molecular genetic tests)
    Provider instructionFollow Carelon prior authorization processes for codes managed by Carelon

    Covered Indications

    Various diagnostic and angiographic imaging indications as per CPT descriptions

    Various diagnostic and angiographic imaging indications as per CPT descriptions: Includes diagnostic CT/MR studies and angiographic variants described by CPT (examples: low-dose CT for lung cancer screening 71271; CT/MR angiography and CTA codes for thorax/abdomen/pelvis; CT chest/brain/neck/orbit variants).

    Select the code that matches the anatomic region and contrast use as described in the CPT code entry.

    PET imaging specific use (breast cancer initial diagnosis / surgical planning) for G0252

    PET for initial breast cancer staging: G0252: PET imaging for initial diagnosis of breast cancer and/or surgical planning (including evaluation of axillary nodal disease) as specified by the CPT/HCPCS description.

    Managed by Carelon per the code entry.

    Policy Revision History

    2025-01-01criteria_updateLatest

    Medical necessity criteria for numerous advanced imaging CPT codes were revised to add 'site of care' requirements effective 01/01/2025; these codes are managed by Carelon for prior authorization determinations.

    2025-04-01code_retirement

    Select molecular/genetic panel duplication/deletion CPT codes (e.g., 81433, 81436, 81438) are scheduled to retire effective 04/01/2025.

    2025-04-01code_retirement

    Some Category III HCPCS U-codes are marked as retiring effective 04/01/2025 (examples include 0428U and 0448U as listed in code entries).

    2025-07-01code_retirement

    Additional Category III codes are scheduled to retire effective 07/01/2025 (examples include 0396U and at least one other U-code with a 07/01/2025 retirement date).

    2025-07last_review

    Document last reviewed in July 2025 with multiple code effective/retirement dates noted through 07/01/2025.

    Policy Summary
    PayerBlue Cross Blue Shield - New Mexico
    PolicyAdvanced Imaging/Radiology prior authorization code list (site-of-care updates)
    Policy CodePolicy N/A
    Change TypeMedical necessity criteria revisedcode additions/retirements
    Effective DateJan 1, 2025
    Next Review DateN/A
    Key ActionSubmit prior authorization requests to the listed manager (Carelon or BCBSNM) and include site-of-care information where required.
    SourceLink
    On This Page
    Coverage Criteria and Medical NecessityCPT/HCPCS Code ListingsProvider Actions, Prior Authorization & DocumentationPrior Authorization SummaryContrast Material and Study Sequencing RulesBackground and ScopeDefinitions and AbbreviationsCovered IndicationsPolicy Revision History

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.